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Jennie T. Mathew, Pharm.D. and Jarrod W. Kile, R.Ph.
Lehigh Valley Health Network • Allentown and Bethlehem, Pennsylvania

Purpose
The objective of this study is to retrospectively evaluate the impact of pharmacist
interventions on vancomycin serum concentrations.
Background
Literature
• To monitor vancomycin efficacy, the 2009 Infectious Disease Society of America/
American Society of Health-System Pharmacists consensus review recommends
obtaining serum trough concentrations, instead of both peak and trough concentrations.
– It is recommended that trough serum concentrations should be obtained just prior
to the fourth dose.1

Study Population
• Inclusion criteria
– Inpatient adults greater than 18 years old.
– Patients who had a minimum of one serum vancomycin concentration obtained
from December 2009 to January 2010.
– Patients who had a minimum of one serum vancomycin concentration obtained
from September 2010 to October 2010.
• Exclusion criteria
– Patients admitted to the transitional skilled unit, hospice, or the long term acute
care facility.

Lehigh Valley Health Network (LVHN)
• Historically, providers at LVHN utilized physician order entry to order vancomycin
serum concentrations.
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• The primary outcome of the study is the number of appropriately ordered serum
vancomycin concentrations.

References

– Serum trough concentration prior to the fourth dose.

• The total costs for vancomycin usage and vancomycin serum concentrations at
LVHN in 2007 were $194,966 and $392,022, respectively.
Study Design
• A retrospective chart review of patients admitted to LVHN with a minimum of one serum
vancomycin concentration obtained during the pre- or post intervention periods.
• The pre- and post intervention periods are defined as December 2009 to January 2010
and September 2010 to October 2010, respectively.
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• Collected data will be in relation to the first serum vancomycin concentration
obtained for each patient.

– The cost of total vancomycin usage and the cost to obtain all serum
vancomycin concentrations prior to and after pharmacist intervention.

• The provider may select from the following options:

• The intent of the new process was to create standardization throughout the health
network.

– A random serum concentration will be considered appropriately obtained
when it is acquired within one hour before or one hour after the time the
concentration was to be obtained.

– Demographics (age, gender, weight, serum creatinine, estimated creatinine
clearance).

• Beginning in February 2010, pharmacists timed orders for vancomycin serum
concentrations.

– Serum random concentration at a time designated by the provider.

– A trough serum concentration will be considered appropriately obtained when
it is acquired between the time it was ordered to be obtained and immediately
before the next administered dose.

• Additional data to be collected:

• Lab orders did not require verification by a pharmacist.

– Serum trough concentration prior to the next dose.

• The secondary outcome is the number of appropriately obtained
vancomycin serum concentrations prior to and after pharmacist
intervention.

– Appropriate serum concentrations will be compared pre- and post intervention by
the type of concentrations requested and the time the concentrations were to be
obtained.
– An appropriate serum concentration, based on type, will be defined as an ordered
trough or random concentration. All peak serum concentrations will be deemed
inappropriate.1-5
– An appropriately timed serum concentration will be defined as a trough concentration
obtained within one hour of the fourth or next dose. All random concentrations will be
considered appropriately timed.2-5
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